Sales & Marketing News | pharmaphorum

News

Alex Gorsky will pass leadership of J&J to Joaquin Duato in ...

Johnson & Johnson has appointed Joaquin Duato as chief executive officer to replace long-serving Alex Gorsky, who has been CEO since 2012.

News

Novartis says trials back Beovu safety in diabetic eye disea...

There is plenty of evidence that Novartis' ophthalmology drug Beovu can match its rivals when it comes to efficacy, with less frequent dosing, but the big question facing the company is whe

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

Years after Pfizer merger, ex-Medivation exec gets insider t...

A Medivation executive at the heart of the company's team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading.

News

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

UK cues up more Pfizer/BioNTech vaccines as price row looms

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have b

News

As the smoke clears, Vectura backs tobacco giant PMI's bid

Vectura's board has decided to recommend a takeover bid from tobacco giant Philip Morris International, despite being urged by health charities to go for a lower offer from investment compa

News

Gene therapy specialist bluebird exits "untenable" European ...

Europe's market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according

Alex Gorsky will pass leadership of J&J to Joaquin Duato in ...

Novartis says trials back Beovu safety in diabetic eye disea...

Years after Pfizer merger, ex-Medivation exec gets insider t...

UK cues up more Pfizer/BioNTech vaccines as price row looms

As the smoke clears, Vectura backs tobacco giant PMI's bid

Gene therapy specialist bluebird exits "untenable" European ...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks